Corporate News – PACS Group, Inc.

Trading Activity

  • PACS shares ended the 24‑hour period on Thursday, 22 October 2026, at USD 47.50, down 2.01 % from the previous close.
  • The 24‑hour trading volume was USD 30.3 million.
  • The company’s market capitalization is USD 7.6 billion.
  • Current share supply is 158.4 million.
  • The 200‑day simple moving average is USD 39.46.
  • The 52‑week high was USD 49.49 (6 August 2026).
  • The 52‑week low was USD 10.31 (14 November 2025).
  • From the end of the previous month, PACS shares have risen 12.59 %.

Insider Transactions

  • PACS Group, Inc. filed a Form 4 with the Securities and Exchange Commission reporting insider sales by its Chief Executive Officer (CEO).
  • The CEO, who also owns approximately 10 % of the company’s shares, sold several thousand shares over a three‑day period in late October.
  • All sales were executed under a pre‑established trading plan.
  • The transactions resulted in a final post‑sale holding of just over 52 million shares.
  • No new shares were issued or acquired as part of these transactions.
  • Sale prices varied within a narrow range, and the CEO remains a significant minority shareholder following the sales.
CompanyTicker% ChangeCurrent Price (USD)Market Cap (USD bn)P/E Ratio
Element Solutions Inc.ESI+1.88 %33.118.948.63
Bruker CorporationBRKR+5.69 %57.318.9–
Tetra Tech, Inc.TTEK+0.26 %36.819.020.87
Protagonist Therapeutics, Inc.PTGX+0.07 %139.538.9113.83
Twist Bioscience CorporationTWST+4.51 %135.479.0–

Note: P/E ratios for Bruker and Twist Bioscience are not disclosed in the available data.